Revolutionary Treatment Overcomes Metastasis and Chemotherapy Resistance in Cancer
Scientists have made a groundbreaking discovery in cancer research by identifying a molecule called Netrin-1 that contributes to cancer metastasis and resistance to therapy. Blocking Netrin-1 reduces the process of epithelial-mesenchymal transition (EMT), which enables cancer cells to spread and acquire resistance to treatment. Early trials in humans have shown promise, with the administration of an anti-Netrin-1 antibody leading to a reduction in tumor formation, inhibition of EMT, and increased sensitivity to chemotherapy. Further research will explore the broader applicability of this treatment and its impact on survival rates in different types of cancers.
